SURGICAL STUDIES OF ONTOGENY, AGING AND THE GUT
SURGICAL STUDIES OF ONTOGENY, AGING AND THE GUT
批准号:
2712124
负责人:
Bernard Mark Evers
金额:
$23.53万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2002-05-31
关键词:
DNA binding protein age difference aging athymic mouse clinical research colon neoplasms developmental genetics gene expression genetic regulatory element genetic transcription genetically modified animals growth /development hormone regulation /control mechanism human subject immature animal intestinal mucosa jejunum laboratory rat mature animal neoplasm /cancer genetics neurotensin posttranscriptional RNA processing reporter genes small intestines
中文摘要
肠道的分化和随后的发育代表了
重要的临床课题,但迄今为止,人们对它知之甚少。
基因组的开启或关闭是有序和同步的,
肠从未分化的内胚层演变为
它的成年分化形式;这些基因表达的变化是
主要由基因的激活或抑制介导
转录。我们之前的发现已经确定了晚期-
分化的神经降压素(NT)基因(命名为NT/N)作为一个优秀的
分子模型来描绘复杂的细胞机制,
导致分化区域特异性表达模式
专门的功能。我们已经证明,NT/N表达是
在不同的时间和空间上受到发育调控
特定模式; NT/N表达最初在胎儿中较低,但
在出生后迅速增加,
地形分布与增加NT/N表达沿着
小肠的纵轴。在人类结肠中,NT/N是
在胎儿中短暂表达,但在成人中被抑制;
然而,NT/N在某些结肠癌中重新表达。中央
我们的建议的假设仍然是,严格的表达
肠道中的NT/N模式受以下机制调节:
主要是转录调控。为了检验这个假设,我们有
具有以下具体目标的实验:(l)我们将进一步
明确NT/N发展模式的调控因素
在肠道中的表达。(2)我们将确定导致
在结肠癌中异位NT/N表达。(3)我们将描述
年龄相关的NT/N表达变化和NT介导的生长,
直觉(4)我们将在体内分析所需的NT/N调控元件
肠道中严格的表达模式。为了实现这一目标,我们
将开发具有人NT/N调节区的转基因品系
连接到报告基因,以确定所需的元件,
概括了NT/N表达的正常发育模式。的
我们研究的最终目标是确定分子机制
在体内调节NT/N表达。了解蛋白质-DNA
限制NT/N表达所需的相互作用将
产生重要的信息的监管和实现的
分化的肠道表型。此外,分析这些细胞
不仅能更好地理解正常的肠道
发展和功能,但也可以提供一个模型,以更好地
阐明导致肠道肿瘤形成的细胞事件。
英文摘要
Differentiation and subsequent development of the gut represents an
important clinical topic but one that is, to date, poorly understood.
Sets of genes are turned on or off in an ordered and synchronized
pattern as the intestine evolves from an undifferentiated endoderm into
its adult differentiated form; these changes in gene expression are
mediated primarily by the activation or repression of gene
transcription. Our previous findings have identified the terminally-
differentiated neurotensin (NT) gene (designated NT/N) as an excellent
molecular model to delineate the complex cellular mechanisms regulating
the region-specific patterns of expression which lead to differentiation
and specialized function. We have shown that NT/N expression is
developmentally regulated in a distinctive temporal- and spatial-
specific pattern; NT/N expression is initially low in the fetus but
rapidly increases after birth to assume the distinctive adult
topographical distribution with increasing NT/N expression along the
longitudinal axis of the small bowel. In the human colon, NT/N is
transiently expressed in the fetus but is repressed in the adult;
however, NT/N is reexpressed in certain colon cancers. The central
hypothesis of our proposal continues to be that the strict expression
pattern of NT/N in the gut is regulated by mechanisms which involve
mainly transcriptional regulation. To examine this hypothesis we have
panned experiments with the following SPECIFIC AIMS: (l) We will further
define the factors regulating the developmental pattern of NT/N
expression in the gut. (2) We will determine the mechanisms leading to
ectopic NT/N expression in colon cancers. (3) We will characterize the
age-related alterations of NT/N expression and NT-mediated growth in the
gut. (4) We will analyze in vivo the NT/N regulatory elements required
for the strict expression pattern in the gut. To achieve this goal, we
will develop transgenic lines with the human NT/N regulatory region
linked to a reporter gene to determine the elements that are required to
recapitulate the normal developmental pattern of NT/N expression. The
ultimate goal of our studies is to define the molecular mechanisms
regulating NT/N expression in vivo. Understanding the protein-DNA
interactions that are required for restricting NT/N expression will
yield important information on the regulation and attainment of the
differentiated gut phenotype. In addition, analysis of these cellular
processes will provide a better understanding of not only normal gut
development and function but may also provide a model to better
elucidate the cellular events leading to gut neoplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
-
批准号:10748123
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2023
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10001327
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10245140
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10475257
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
-
批准号:10227741
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms regulating neurotensin secretion and function
-
批准号:9219942
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms Regulating Neurotensin Secretion and Function
-
批准号:10536470
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms Regulating Neurotensin Secretion and Function
-
批准号:10651886
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis
-
批准号:9547788
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2015
-
负责人:Bernard Mark Evers
-
依托单位:
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis
-
批准号:9753735
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2015
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:9208386
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:8883529
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:8773989
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:9298655
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Administration
-
批准号:10470101
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Interdisciplinary Research Training in Cancer Biology
-
批准号:8475191
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
-
批准号:9275578
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
-
批准号:9120005
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Leadership, Planning and Evaluation
-
批准号:10204900
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Developmental Funds
-
批准号:10204899
-
项目类别:
-
资助金额:$27.97万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
海外基金